Bayer Returns To Q2 Profit, Sales Edge Up; Confirms Outlook

Latest Headlines

Top Stories

Breaking News

Stock Alerts

Wallstreet Events

Industry News

Industry News

Corp. Calendars

Stock Splits

Conference Calls

Earnings Calendar

Earnings Calendar

Pos Pre-announcements

Profit Warnings

Positive Surprise

Negative Surprise

Latest Earnings

FDA Calendars

Drug Approvals

Clinical Trial Calendar

Ratings Changes

Cov Initiations

Cov. Reiterated

Economic News

Economic Calendar

Economic Scorecard

Cryptocurrency

Cryptocurrency

Morning Mkt Analysis

US Commentary

European Commentary

Asian Commentary

Canadian Commentary

Indian Commentary

Commodities

White House

General News

FX Top Stories

Currency Analysis

Currency Alerts

Economic Calendar

Economic Scorecard

Coronavirus

COVID-19 Calendar

Diet & Fitness

Kids Health

Men’s Health

Women’s Health

Cancer News

Drug Development

Mental Health

Slide Shows

Entertainment

Entertainment

Top Stories

Classic Rock

Rap/Hip-Hop

Alternative

Content Licensing

Content Licensing

Newswires & Feeds

Content Syndication

Digital Signage Services

Radio News Services

Premium Services

Intelligent Investor

Biotech Investor NEW

Latest News Videos

Free Content

Press Releases

Latest Headlines

Stock Alerts

Top Stories

Breaking News

Wallstreet Events

Industry News

Corp. Calendars

Stock Splits

Conference Calls

Earnings Calendar

Earnings Calendar

Pos Pre-announcements

Profit Warnings

Positive Surprise

Negative Surprise

Latest Earnings

FDA Calendars

Drug Approvals

Clinical Trial Calendar
Ratings Changes

Cov Initiations

Cov. Reiterated

Economic Calendar

Economic Scorecard

Cryptocurrency

Market News

Morning Mkt Analysis

US Commentary

European Commentary

Asian Commentary

Canadian Commentary

Indian Commentary

Commodities

White House

General News

FX Top Stories

Currency Analysis

Currency Alerts

Economic Calendar

Economic Scorecard

Health News

Coronavirus

COVID-19 Calendar

Diet & Fitness

Kids Health

Men’s Health

Women’s Health

Cancer News

Drug Development

Mental Health

Slide Shows

Entertainment

Entertainment News

Top Stories

Classic Rock

Rap/Hip-Hop

Alternative

Content Licensing

Newswires & Feeds

Content Syndication

Digital Signage Services

Radio News Services

Intelligent Investor

Biotech Investor

Latest News Videos

Free Content

Press Releases

Quick Facts

Bayer Returns To Q2 Profit, Sales Edge Up; Confirms Outlook

By RTTNews Staff Writer โœ‰
| Published: 8/4/2026 2:20 AM ET

Addas your preferred news source on Google

German pharmaceutical and biotechnology company Bayer AG (BYR.L) returned to profit in the second quarter, primarily helped bysignificantly lower other operating expenses.
Net income attributable to Bayer stockholders was โ‚ฌ219 million, or โ‚ฌ0.23 per share, compared with a loss of โ‚ฌ199 million, or โ‚ฌ0.20 per share, a year earlier.
Other operating expenses declined sharply to โ‚ฌ569 million from โ‚ฌ2.111 billion a year earlier.
Excluding one-time items, core net income from continuing operations, however, decreased toโ‚ฌ934 million or โ‚ฌ0.95 per share from โ‚ฌ1.122 billion or โ‚ฌ1.14 per share a year earlier.
EBIT surged to โ‚ฌ827 million from โ‚ฌ13 million last year.
EBIT before special items was โ‚ฌ999 million, 0.5% up from โ‚ฌ994 million in the prior year.
EBITDA rose to โ‚ฌ1.985 billion from โ‚ฌ285 million a year ago, while EBITDA before special items increased 1.9% to โ‚ฌ2.144 billion from โ‚ฌ2.105 billion.

Net sales edged up 1.2% to โ‚ฌ10.872 billion from โ‚ฌ10.739 billion in the prior-year quarter.
By segment, Crop Science sales increased to โ‚ฌ4.910 billion from โ‚ฌ4.788 billion a year earlier, driven by a 2.6% increase in volume and a 0.9% improvement in pricing.
Pharmaceuticals sales were broadly unchanged from the prior-year quarter, as strong growth from Nubeqa, Kerendia and the Radiology business largely offset declines in Eylea and Xarelto following patent expirations.
Consumer Health posted slightly higher sales, supported by growth across most product categories, led by Digestive Health, which was partly offset by weaker Allergy & Cold sales.
Looking ahead, Bayer reaffirmed its currency-adjusted 2026 guidance, continuing to expect sales of โ‚ฌ45 billion to โ‚ฌ47 billion, representing flat to 3% growth year over year. Core earnings per share is still expected at โ‚ฌ4.30 to โ‚ฌ4.80.
For comments and feedback contact: editorial@rttnews.com
Business News

Slide Shows

Biotech Stocks Facing FDA Decision In August 2026

Biotech Stocks Facing FDA Decision In July 2026

Biotech Stocks Facing FDA Decision In June 2026

Next Story

Latest Updates on Middle East War

U.S. Dollar Ticked Higher As Tumbling Crude Oil Prices Ease Inflationary Pressures
August 03, 2026 16:59 ET

Crude Oil Nosedives After Trump Calls Off Planned Attacks On Iran
August 03, 2026 14:49 ET

Canadian Stocks Slide Amid Persisting Middle East Tensions, GDP Data Release
July 31, 2026 16:31 ET

Gold Surges As Investors Parse Fed’s Interest Rate Decision Amid Middle East Tensions
July 30, 2026 13:37 ET

Gold Slides Amid U.S.-Iran Standoff Despite Trump Canceling Planned Attacks
August 03, 2026 13:44 ET

Global Economics Weekly Update – July 27 โ€“ July 31, 2026

August 01, 2026 02:10 ET
Major central banks, led by the U.S. Federal Reserve, and preliminary estimates of second quarter economic growth dominated the economics news flow this week. In the U.S., the Federal Reserve announced its latest policy decision and early estimates of second quarter growth and monthly inflation data were also released. In Europe, the interest rate decision from the Bank of England was in focus. Similarly, the Bank of Japan was in the limelight in Asia for its policy announcement.

View More Videos

RELATED NEWS

Bayer Consolidates U.S. Glyphosate Business Into Ruveon

Bayer Receives FDA Approval For AMBELVIST For Contrast-Enhanced MRI

Bayer’s MRI Contrast Agent Ambelvist Wins FDA Approval

Bayer Wins FDA Priority Review For Kerendia In Chronic Kidney Disease With Type 1 Diabetes

Bayer Granted Priority Review For Asundexian In Secondary Stroke Prevention

Latest Updates on COVID-19

Most Emailed

Xerox Stock Up 26% On Q2 Turnaround, Raised FY26 Outlook
July 30, 2026 08:42 ET

Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook
July 30, 2026 02:02 ET

LG Energy Solution Q2 Operating Income Falls
July 30, 2026 01:06 ET

Gildan Activewear To Sell HanesBrands Australia For A$700 Mln; Lifts Annual Adj. Income Outlook
July 30, 2026 08:31 ET

Intercontinental Exchange To Acquire MarketAxess For $167/shr
July 30, 2026 08:11 ET

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down
July 31, 2026 08:06 ET

Stride Names Robert Knowling CEO To Succeed James Rhyu, Prelim. Profit Climbs; Shares Down
July 30, 2026 10:05 ET

Anthropic’s AI Training Method Under Scrutiny
July 31, 2026 18:02 ET

Amazon’s Zoox Gets Approval For Paid Robotaxi Service In The U.S.
July 30, 2026 17:28 ET

LondonMetric, SREIT To Acquire Picton Property In ยฃ404 Mln Deal
July 31, 2026 08:00 ET

Franklin Resources Announces Name Change
July 31, 2026 09:52 ET

NatWest Q2 Results Climb, Lifts FY26 Income View; Plans Buybacks
July 31, 2026 02:53 ET

Sumitomo Mitsui Trust Group Q1 Net Income Rises
July 30, 2026 07:49 ET

Renault Posts H1 Net Profit As Revenue Improves, Expenses Drop
July 30, 2026 00:44 ET

GKE Corporation Ltd Reveals Retreat In Full Year Income
July 30, 2026 07:50 ET

Samsung Q2 Operating Income Surges On AI Demand; Sees Strong Demand In H2
July 30, 2026 00:54 ET

Lincoln Electric Holdings Inc. Announces Climb In Q2 Profit
July 30, 2026 07:51 ET

Shimizu Corporation Reveals Increase In Q1 Income
July 30, 2026 00:57 ET

Unibail-Rodamco-Westfield H1 Net Rental Income Declines, Announces FY26 Outlook
July 30, 2026 07:57 ET

CTS CO Ltd Q1 Profit Advances
July 30, 2026 01:01 ET

Bombardier Q2 Profit Edges Lower, But Revenue Climbs 6%
July 30, 2026 07:58 ET

Tsugami Corp Q1 Income Climbs
July 30, 2026 01:05 ET

Hutchmed China Ltd. Reveals Fall In H1 Income
July 30, 2026 07:58 ET

LG Energy Solution Q2 Operating Income Falls
July 30, 2026 01:06 ET

Editors Pick

Tyson Foods Q3 Profit Surges
August 03, 2026 09:41 ET

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down
July 31, 2026 08:06 ET

Xerox Stock Up 26% On Q2 Turnaround, Raised FY26 Outlook
July 30, 2026 08:42 ET

GE HealthCare Stock Up 13% On Strong Q2 Profit & Orders, Positive Outlook
July 29, 2026 07:20 ET

Copyright ยฉ 2026 RTTNews. All rights reserved.By using this site, you agree to the
Terms of Service.
About Us |
Contact Us

Original source: us